首页> 外国专利> Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors

Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors

机译:6种氨基喹啉5、8种醌和与衰老相关的核酸在治疗肿瘤中的用途

摘要

Use of at least one 6-amino-quinoline-5,8-quinone (I) for preparing a composition for the treatment of tumors. Independent claims are also included for the following: (1) nucleic acid (II) associated with senescence, which encodes e.g. transcription factor 8, guanylate cyclase 1, mannosidase, fibulin 2, fibrillin 2, laminin, microfibrillar-associated protein 4, angiogenic inducer, heat shock 70kD, protein 4, thioredoxin reductase (Table 2 in specification); (2) recombinant vector (III) containing (II); (3) recombinant cell (IV) transformed or transfected with (II) or (III); (4) polypeptide (V) associated with senescence encoded by (II); and (5) composition (VI) comprising (II), (III) or (V), optionally together with a conventional carrier substance and adjuvants. ACTIVITY : Cytostatic. MECHANISM OF ACTION : Inhibitor of tumor cell proliferation by (I) induced activation of cellular senescence, cell cycle arrest, apoptosis (claimed); Inducer of p21 in a p53-independent manner. No supporting data is given.
机译:至少一种6-氨基喹啉-5,8-醌(I)在制备用于治疗肿瘤的组合物中的用途。还包括针对以下方面的独立权利要求:(1)与衰老相关的核酸(II),其编码例如H2O3。转录因子8,鸟苷酸环化酶1,甘露糖苷酶,丝蛋白2,原纤维蛋白2,层粘连蛋白,微纤维相关蛋白4,血管生成诱导剂,热休克70kD,蛋白4,硫氧还蛋白还原酶(规格表2); (2)含有(II)的重组载体(III); (3)用(II)或(III)转化或转染的重组细胞(IV); (4)与(II)编码的衰老相关的多肽(V); (5)组合物(VI),其包含(II),(III)或(V),任选地与常规载体物质和助剂一起。活动:细胞静息。作用机理:通过(I)诱导细胞衰老,细胞周期阻滞,细胞凋亡的活化来抑制肿瘤细胞的增殖(声称);以p53无关的方式诱导p21。没有提供支持数据。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号